RxSight stake of 7.3% reported by Millennium group
RxSight, Inc. is reported to have 3,030,287 shares of its common stock beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, representing 7.3% of the class as of June 30, 2026.
Rhea-AI Filing Summary
RxSight, Inc. is reported to have 3,030,287 shares of its common stock beneficially owned by Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander, representing 7.3% of the class as of June 30, 2026. Each reporting person lists 0 shares with sole voting or dispositive power and 3,030,287 shares with shared voting and shared dispositive power. The securities are held by entities subject to voting control and investment discretion of Millennium Management LLC and/or other investment managers controlled by Millennium Group Management LLC and Mr. Englander, and the reporting persons state that this description should not by itself be construed as an admission of beneficial ownership. A Joint Filing Agreement dated August 3, 2026 is included as an exhibit.
Positive
- None.
Negative
- None.
Key Figures
Key Terms
beneficially owned financial
disposition of financial
Joint Filing Agreement regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What ownership stake in RxSight, Inc. (RXST) is reported in this Schedule 13G/A?
Who are the reporting persons in the RxSight (RXST) Schedule 13G/A amendment?
Do the Millennium entities and Israel A. Englander admit full beneficial ownership of RxSight (RXST) shares?
What exhibit accompanies this RxSight (RXST) Schedule 13G/A filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.